您当前所在的位置:首页 > 产品中心 > 产品详细信息
103628-46-2 分子结构
点击图片或这里关闭

1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide

ChemBase编号:551
分子式:C14H21N3O2S
平均质量:295.40044
单一同位素质量:295.13544793
SMILES和InChIs

SMILES:
S(=O)(=O)(NC)Cc1cc2c(CCN(C)C)c[nH]c2cc1
Canonical SMILES:
CNS(=O)(=O)Cc1ccc2c(c1)c(CCN(C)C)c[nH]2
InChI:
InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3
InChIKey:
KQKPFRSPSRPDEB-UHFFFAOYSA-N

引用这个纪录

CBID:551 http://www.chembase.cn/molecule-551.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide
IUPAC传统名
sumatriptan
商标名
Imigran
Sumatran
Sumax
Imitrex
Imitrex Oral
Imitrex, Imigran ,Treximet
别名
Sumatriptan Succinate
Sumatriptanum [INN-Latin]
NP101
sumatriptan
triptan
Sumatriptan
SUMATRIPTAN SUCCINATE
CAS号
103628-46-2
103628-48-4
PubChem SID
160964014
46506520
PubChem CID
5358
CHEBI ID
10650
ATC码
N02CC01
CHEMBL
128
Chemspider ID
5165
DrugBank ID
DB00669
IUPHAR配体索引
54
KEGG ID
D00451
美国药典/FDA物质标识码
8R78F6L9VO
维基百科标题
Sumatriptan

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID 价格
苏州艾佳
AJA-O40223 external link 加入购物车 请登录

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 11.244988  质子受体 3 
质子供体 2  LogD (pH = 5.5) -2.4983597 
LogD (pH = 7.4) -1.2358891  Log P 0.7419289 
摩尔折射率 82.0842 cm3 极化性 33.330933 Å3
极化表面积 65.2 Å2 可自由旋转的化学键 5 
里宾斯基五规则 true 
Log P 1.17  LOG S -3.37 
溶解度 1.27e-01 g/l 

分子性质

分子性质

理化性质 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
21.4 mg/ml expand 查看数据来源
疏水性(logP)
0.8 expand 查看数据来源
给药途径
tablet, subcutaneous injection, nasal spray expand 查看数据来源
生物利用度
15% (oral)/ 96% (s.c) expand 查看数据来源
排泄
60% urine; 40% feces expand 查看数据来源
半衰期
2.5 hours expand 查看数据来源
代谢
MAO expand 查看数据来源
蛋白结合率
14%-21% expand 查看数据来源
法定药品分级
Rx-only (US) expand 查看数据来源
妊娠期药物分类
C expand 查看数据来源
美国(FDA)药品许可证
Sumatriptan expand 查看数据来源
纯度
98% expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank Wikipedia Wikipedia
DrugBank -  DB00669 external link
Item Information
Drug Groups approved; investigational
Description A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of migraine disorders. A transdermal patch version of sumatriptan is currently in phase I trials in the U.S. under the code name NP101 (NuPathe).
Indication For the treatment of migraine attacks with or without aura.
Pharmacology Sumatriptan, an antimigraine drug, is a selective agonist of vascular serotonin ((5-hydroxytryptamine; 5-HT) type 1-like receptors, likely the 5-HT1D and 5-HT1B subtypes. It has no significant affinity (as measured using standard radioligand binding assays) or pharmacological activity at 5-HT2, 5-HT3 receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic; dopamine1; dopamine2; muscarinic; or benzodiazepine receptors.
Toxicity Symptoms of overdose include convulsions, tremor, paralysis, inactivity, ptosis, erythema of the extremities, abnormal respiration, cyanosis, ataxia, mydriasis, salivation, and lacrimation.
Affected Organisms
• Humans and other mammals
Biotransformation Hepatic. In vitro studies with human microsomes suggest that sumatriptan is metabolized by monoamine oxidase (MAO), predominantly the A isoenzyme.
Absorption Approximately 15%
Half Life 2.5 hours
Protein Binding 14%-21%
Elimination Only 3% of the dose is excreted in the urine as unchanged sumatriptan; 42% of the dose is excreted as the major metabolite, the indole acetic acid analogue of sumatriptan.
Distribution * 2.7 L/kg [subcutaneous dosing]
Clearance * 1200 mL/min [Following a 6-mg SC injection]
References
• Nikai T, Basbaum AI, Ahn AH: Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain. 2008 Oct 31;139(3):533-40. Epub 2008 Aug 23. [Pubmed]
External Links
• Wikipedia
• RxList
• Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Nikai T, Basbaum AI, Ahn AH: Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain. 2008 Oct 31;139(3):533-40. Epub 2008 Aug 23. Pubmed
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle